Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF Mutations Open Doors for N-Ethyl-N-Nitrosourea-Induced Gliomagenesis.

The American journal of pathology - 1 Oct 2016

McNeill Robert S, Irvin David M, Miller C Ryan

Abstract excerpt

This commentary highlights the article by Wang et al that describes a preclinical model for targeting BRAF-mutant gliomas.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hearing Loss, Sensorineural
Share to Ethylnitrosourea
Share to BRAF gene
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 27543966
DOI: 10.1016/j.ajpath.2016.07.005
PMCID: PMC5222976

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF Mutations Open Doors for N-Ethyl-N-Nitrosourea-Induced Gliomagenesis.PMID 27543966Read ↗

BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic Targets.Semantic proximity Read ↗

The role of BRAF-targeted therapy in astrocytomas: a review.Semantic proximity Read ↗

Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea.Semantic proximity Read ↗

A critical review of RAF inhibitors in BRAF-mutated glioma treatment.Semantic proximity Read ↗

Tovorafenib effective against low-grade gliomas harbouring BRAF fusions.Semantic proximity Read ↗

Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant GliomasSemantic proximity Read ↗

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.Semantic proximity Read ↗

GBM radiosensitizers: dead in the water…or just the beginning?Semantic proximity Read ↗

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus MutantSemantic proximity Read ↗

Advancements on the zebrafish glioma model.Semantic proximity Read ↗

BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain TumorsSemantic proximity Read ↗

The Present State of Antineoplaston Research (1)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.